Financial Summary (All financials)
| In millions, except per share items | Dec-31-22 | Dec-31-21 | Dec-31-20 | Dec-31-19 | Dec-31-18 | Dec-31-17 | Dec-31-16 | Dec-31-15 |
| Revenues | 11,609.9 | 11,618.8 | 11,550.6 | 11,388.5 | 11,404.9 | 10,876.6 | 10,707.5 | 9,982.2 |
| Revenue growth | -0.1% | 0.6% | 1.4% | -0.1% | 4.9% | 1.6% | 7.3% | -22.0% |
| Cost of goods sold | 8,209.6 | 7,972.4 | 8,004.9 | 7,914.5 | 8,149.4 | 7,930.6 | 7,083.9 | 6,865.3 |
| Gross profit | 3,400.3 | 3,646.4 | 3,545.7 | 3,474.0 | 3,255.4 | 2,946.1 | 3,623.6 | 3,116.9 |
| Gross margin | 29.3% | 31.4% | 30.7% | 30.5% | 28.5% | 27.1% | 33.8% | 31.2% |
| General and administrative | 1,355.2 | 1,195.3 | 1,247.6 | 1,103.3 | 1,135.5 | 1,064.0 | 1,072.8 | 1,031.1 |
| EBITA | 1,350.5 | 1,810.2 | 1,724.7 | 1,782.5 | 1,489.0 | 1,340.3 | 1,698.3 | 1,655.0 |
| EBITA margin | 11.6% | 15.6% | 14.9% | 15.7% | 13.1% | 12.3% | 15.9% | 16.6% |
| Amortization of intangibles | 11.5 | 12.9 | 13.8 | 14.2 | 16.2 | 15.8 | 14.6 | 19.2 |
| EBIT | 1,339.1 | 1,797.4 | 1,710.9 | 1,768.2 | 1,472.8 | 1,324.5 | 1,683.8 | 1,635.8 |
| EBIT margin | 11.5% | 15.5% | 14.8% | 15.5% | 12.9% | 12.2% | 15.7% | 16.4% |
| Pre-tax income | 966.3 | 1,518.5 | 1,318.3 | 1,195.4 | 1,048.5 | 1,399.8 | 1,623.1 | 688.4 |
| Income taxes | 198.1 | 306.7 | 313.9 | 279.6 | 258.4 | 323.9 | 431.8 | 207.5 |
| Tax rate | 20.5% | 20.2% | 23.8% | 23.4% | 24.6% | 23.1% | 26.6% | 30.1% |
| Earnings from continuing ops | 546.9 | 978.5 | 1,787.6 | 705.5 | 1,406.5 | 1,984.9 | 2,229.5 | 804.1 |
| Earnings from discontinued ops | 13.5 | | -9.7 | 105.5 | -457.0 | -245.4 | -158.3 | -53.5 |
| Net income | 560.4 | 978.5 | 1,778.0 | 811.0 | 949.5 | 1,739.5 | 2,071.2 | 750.6 |
| Net margin | 4.8% | 8.4% | 15.4% | 7.1% | 8.3% | 16.0% | 19.3% | 7.5% |
| |
| Diluted EPS | $5.71 | $8.90 | $14.58 | $4.59 | $8.16 | $10.37 | $10.88 | $3.72 |
| Shares outstanding (diluted) | 95.8 | 109.9 | 122.6 | 153.8 | 172.4 | 191.3 | 204.9 | 216.3 |
| |
| EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |
|